CVS Health stock gains as split plan meets higher 2026 outlook

Published on 11/11/2026 at 15:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CVS Health stock gains as the company advances a planned two-company split. Stronger quarterly results support higher 2026 earnings and cash-flow targets.

Split Plan Meets Stronger Results

CVS Health plans to separate its healthcare solutions and retail pharmacy operations into two public companies by the first half of 2028.
Third-quarter revenue increased 5.4 percent, while adjusted earnings per share rose to 2.09 US dollars.
Management raised its 2026 adjusted earnings-per-share floor to 8.20 US dollars and its operating cash flow target to 15.5 billion US dollars.

CVS Health Corp., US1266501006, Illustration mit AI erstellt.

CVS Health stock has extended its rebound as investors weigh the company's planned separation against stronger third-quarter operating results. The latest move adds a fresh market signal to the strategic reset announced on November 4, 2026.

CVS Health stock traded at 79.81 euros on Lang & Schwarz at 15:31 CET on Wednesday, November 11, 2026, 2.85 percent above the Xetra close of Tuesday, November 10. The quote was 76.78 euros in the previous report published on November 10, putting the latest level 3.95 percent higher over that separate reporting period.

Two Businesses, One Long Transition

According to the CVS Health announcement, the healthcare solutions company will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. CVS Pharmacy will comprise approximately 9,000 retail pharmacies, mail pharmacy services, MinuteClinic and Health100.

The separation is expected in the first half of 2028. It remains subject to final board approval, an effective Form 10 registration statement and confirmation of the intended tax treatment. Existing shareholders are expected to receive shares in both companies, but the final allocation of assets, liabilities and capital remains an execution issue.

Quarterly Recovery Lifts Targets

CVS Health reported third-quarter revenue of 108.4 billion US dollars for the period ended September 30, 2026, up from 102.9 billion US dollars a year earlier. Adjusted earnings per share rose to 2.09 US dollars from 1.60 US dollars, while adjusted operating income increased to 4.194 billion US dollars from 3.459 billion US dollars.

The company's results release shows that adjusted earnings guidance for 2026 was raised to at least 8.20 US dollars per share from a previous range of 7.90 to 8.10 US dollars. The operating cash flow target increased to at least 15.5 billion US dollars from at least 11.5 billion US dollars. Management nevertheless cited elevated cost trends and potential macroeconomic headwinds.